New England Deaconess Hosp — Boston, Massachusetts

New England Deaconess Hosp is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

New England Deaconess Hosp has participated in 10 clinical trials.

Therapeutic areas: Sarcoma, Kaposi, HIV Infections, Chickenpox.

Sponsors: Nexstar Pharmaceuticals, National Institute of Allergy and Infectious Diseases (NIAID), Amgen.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New England Deaconess Hosp?

New England Deaconess Hosp has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New England Deaconess Hosp conducted?

New England Deaconess Hosp has 10 clinical trials on record. Their work covers Sarcoma, Kaposi, HIV Infections, Chickenpox.

Is New England Deaconess Hosp accredited by Crixeo Health?

Yes — New England Deaconess Hosp holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New England Deaconess Hosp?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.